Wedbush Reiterates Outperform Rating on Neurocrine Biosciences, Inc. (NBIX)
Rating Change Wedbush analysts reiterated a Outperform rating on Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on August 03, 2026. Market Context Neurocrine Biosciences, Inc.
Read more
